Tigecycline, the first glycylcycline-class drug, is a broad-spectrum antibiotic with activity against multidrug resistant (MDR) organisms. We describe a case of sustained and severe hypoglycemia in a patient treated with tigecycline for pneumonia due to MDR Klebsiella pneumoniae. | Tigecycline-induced sustained severe hypoglycemia: A case report